What are the Epidemiological Implications of PSA Screening?
PSA screening has been the subject of considerable debate in the epidemiological community. While PSA screening can detect prostate cancer at an early stage, it also has limitations, including false positives and overdiagnosis. These limitations can lead to unnecessary biopsies and treatments, causing potential harm and increasing healthcare costs. Epidemiologists study the balance between the benefits and drawbacks of PSA screening to provide evidence-based recommendations for prostate cancer screening guidelines.
